Mach7 Technologies Announces the Next Phase in Empowering AI within Radiology Reading Workflow

The integrated solution introduces the Mach7 eUnity Diagnostic Viewer within the radiologist's standard PowerScribe One workflow, pre-populating the report with data produced by AI models.

FREMONT, CA: Mach7, a leading provider of data management and enterprise imaging solutions for healthcare organizations, has announced the beginning of the clinical validation phase for a new solution that integrates Mach7s advanced zero-footprint eUnity Diagnostic Viewer within Nuance Communication's cloud-hosted PowerScribe One radiology platform. Innovated in collaboration with Nuance, the integrated solution can boost the at-scale adoption of AI models from the Nuance AI Marketplace for Diagnostic Imaging within PowerScribe One reports for improved patient outcomes.

The integrated solution introduces the Mach7 eUnity Diagnostic Viewer within the radiologist's standard PowerScribe One workflow, pre-populating the report with data produced by AI models. The radiologist can then review as well as edit the AI results directly in the eUnity Diagnostic Viewer, with all adjustments and findings automatically updated in the report without requiring repeated dictation. That lowers turnaround times for reporting findings to refer physicians as well as improves radiology report completeness and accuracy.

"As AI becomes increasingly more important and more developed as part of the radiology reading workflow, it is important that Mach7 provide healthcare professionals with the tools to drive the utilization of the latest innovative AI technologies. Through our collaboration with Nuance, and the tight integration of our enterprise viewing platform with the Nuance PowerScribe One solution, we continue to show differentiated value to our customers to improve clinical workflow efficiency and diagnostic confidence," stated Mike Lampron, Chief Executive Officer, Mach7 Technologies.

The Mach7 and Nuance collaboration's primary goal is to give radiologists the ability to choose AI solutions that provide previously unavailable results information as well as add meaningful clinical value to a patient's report.